Arrowhead Pharmaceuticals Inc.

+1.12 (+3.20%)
7:41:44 PM EDT: $36.30 +0.18 (+0.50%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)3.86B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$44.79 Million
Adjusted EPS-$0.60
See more estimates
10-Day MA$35.50
50-Day MA$33.32
200-Day MA$33.35
See more pivots

Arrowhead Pharmaceuticals Inc. Stock, NASDAQ:ARWR

177 East Colorado Boulevard, Suite 700, Pasadena, California 91105
United States of America
Phone: +1.626.304.3400
Number of Employees: 397


Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by R. Bruce Stewart in 1989 and is headquartered in Pasadena, CA.